224 related articles for article (PubMed ID: 21255435)
1. Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription.
Hulf T; Sibbritt T; Wiklund ED; Bert S; Strbenac D; Statham AL; Robinson MD; Clark SJ
BMC Genomics; 2011 Jan; 12():54. PubMed ID: 21255435
[TBL] [Abstract][Full Text] [Related]
2. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
3. miR-196b Is Epigenetically Silenced during the Premalignant Stage of Lung Carcinogenesis.
Tellez CS; Juri DE; Do K; Picchi MA; Wang T; Liu G; Spira A; Belinsky SA
Cancer Res; 2016 Aug; 76(16):4741-51. PubMed ID: 27302168
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
5. Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs.
Das S; Bryan K; Buckley PG; Piskareva O; Bray IM; Foley N; Ryan J; Lynch J; Creevey L; Fay J; Prenter S; Koster J; van Sluis P; Versteeg R; Eggert A; Schulte JH; Schramm A; Mestdagh P; Vandesompele J; Speleman F; Stallings RL
Oncogene; 2013 Jun; 32(24):2927-36. PubMed ID: 22797059
[TBL] [Abstract][Full Text] [Related]
6. Regulatory Mechanism of MicroRNA Expression in Cancer.
Ali Syeda Z; Langden SSS; Munkhzul C; Lee M; Song SJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138313
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of microRNAs in cancer: an integrated review of literature.
Kunej T; Godnic I; Ferdin J; Horvat S; Dovc P; Calin GA
Mutat Res; 2011 Dec; 717(1-2):77-84. PubMed ID: 21420983
[TBL] [Abstract][Full Text] [Related]
8. Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer.
Farooqi AA; Fuentes-Mattei E; Fayyaz S; Raj P; Goblirsch M; Poltronieri P; Calin GA
Semin Cancer Biol; 2019 Oct; 58():47-55. PubMed ID: 30742906
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of miR-196b expression in gastric cancer.
Tsai KW; Hu LY; Wu CW; Li SC; Lai CH; Kao HW; Fang WL; Lin WC
Genes Chromosomes Cancer; 2010 Nov; 49(11):969-80. PubMed ID: 20662076
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide epigenetic regulation of miRNAs in cancer.
Baer C; Claus R; Plass C
Cancer Res; 2013 Jan; 73(2):473-7. PubMed ID: 23316035
[TBL] [Abstract][Full Text] [Related]
12. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling.
Zhao J; Li H; Zhao S; Wang E; Zhu J; Feng D; Zhu Y; Dou W; Fan Q; Hu J; Jia L; Liu L
Mol Cancer; 2021 Mar; 20(1):46. PubMed ID: 33658044
[TBL] [Abstract][Full Text] [Related]
15. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
16. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and Epigenetics.
Moutinho C; Esteller M
Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of microRNA expression in cancer.
Choudhry H; Catto JW
Methods Mol Biol; 2011; 676():165-84. PubMed ID: 20931397
[TBL] [Abstract][Full Text] [Related]
19. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of miR-129-2 and its effects on the proliferation and invasion in lung cancer cells.
Xiao Y; Li X; Wang H; Wen R; He J; Tang J
J Cell Mol Med; 2015 Sep; 19(9):2172-80. PubMed ID: 26081366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
